A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 108.03
GOOG 769.64
MSFT 57.95
FB 123.48
BAC 15.40

Recently Added

ACBI 15.56
QHC 6.02
LOAN 5.83
BEBE 0.83
AG 13.12

Gaining Speed

ACBI 15.56
QHC 6.02
HCN 76.29
CCC 14.29
CPIX 4.65

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!